Showing 51 - 60 of 36,034
Crohn's disease is a chronic inflammatory bowel disease of unknown aetiology which affects around 35 000 people in the UK (population 56.8 million). The potential for onset in early adult life, disease chronicity and a need for hospitalisation and surgery mean that the disease can be associated...
Persistent link: https://www.econbiz.de/10005590309
Objective: To estimate the cost of lost work days due to ischaemic heart disease (IHD), and the cost of this reduced productivity using reduction in household income. Design and setting: Using 2 years of nationally representative observational data, this study examined the effect on household...
Persistent link: https://www.econbiz.de/10005590333
The effectiveness of drug treatment in clinical practice is considerably lower than the efficacy shown in controlled studies. The lower effectiveness in practice presumably leads to lower cost effectiveness of drug treatment in real-life situations compared with that demonstrated by studies...
Persistent link: https://www.econbiz.de/10005590347
It has been suggested that the annual direct costs for irritable bowel syndrome (IBS) are now around $US41 billion in the 8 most industrialised countries. This paper reviews the data on calculations of direct costs. The true economic burden is unclear, as there are insufficient data on indirect...
Persistent link: https://www.econbiz.de/10005590450
Issues related to avoidable mortality in people with epilepsy have been highlighted in the National Sentinel Clinical … Audit of Epilepsy-Related Death in the UK. This audit concluded that 39% of adult epilepsy-related deaths and 59% of … epilepsy-related deaths in children were potentially or probably avoidable. Particular attention was drawn to the important and …
Persistent link: https://www.econbiz.de/10005448920
The objective of this review was to overview published cost-of-illness (COI) studies of epilepsy and their … methodological approaches. Epilepsy imposes a substantial burden on individuals and society as a whole. The mean prevalence of … epilepsy is estimated at 0.52% in Europe, 0.68% in the US, and peaks up to 1.5% in developing countries. Estimation of the …
Persistent link: https://www.econbiz.de/10005449132
Chronic disease and collaboration (people The aim of this article is to outline four approaches to collaboration - epidemiologically focused collaborations, research-based consortiums, organizational-change collaborations, and patient-focused disease management strategies - currently employed to...
Persistent link: https://www.econbiz.de/10005404738
treatment for refractory epilepsy from the Canadian Ministry of Health perspective. The main objective is to estimate the …-controlled trials performed in 904 patients, aged 16-70 years, with at least 1 year history of epilepsy, two to four partial seizures … increased cost of treating patients (with refractory epilepsy) with levetiracetam may be partially offset by a reduction in …
Persistent link: https://www.econbiz.de/10005404895
preference discrete choice experiment (DCE) was used to explore the preferences of people with epilepsy regarding the adverse … expert consultation. In addition, a national epilepsy patient advocacy group helped to identify important attributes and … hundred members of a national patient advocacy group with a diagnosis of epilepsy were presented with pairs of hypothetical …
Persistent link: https://www.econbiz.de/10005404982
Epilepsy is a common neurological disease, which affects people of all ages. Patients often have deficits regarding … their knowledge of epilepsy. Many of them have recurrent seizures, psychosocial, and emotional problems and report … restrictions in daily living as a result of their epilepsy. Meanwhile, a variety of psychoeducational programs have been developed …
Persistent link: https://www.econbiz.de/10005590079